Fundraising Fox
University of Cambridge Enterprise
Government fundCambridge · Pre-Seed–Seed · 14 people tracked
Find your way into University of Cambridge Enterprise
Sign up to see every warm intro you have to University of Cambridge Enterprise
- Paths you didn't know you had: your email and LinkedIn already hold routes to the University of Cambridge Enterprise team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Cambridge Enterprise serves as the innovation and commercialization arm of the University of Cambridge, helping researchers, innovators, and teams translate academic research into real-world impact. It provides a range of support spanning early idea development through to investment, backing next-generation ideas, expertise, and spinouts emerging from the University. The organization forms collaborations with organizations and industries across the Cambridge ecosystem and beyond, aiming to generate globally-leading economic and social outcomes from Cambridge research.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from curated & public directories
What they invest in
from 27 of 43 portfolio companiesBiotech ×13Deep Tech ×13Healthtech ×13Medical Devices ×12AI & Machine Learning ×8Hardware ×7Digital Health ×5Semiconductors ×4
HQs:United Kingdom×19United States×1
Investments · 43 tracked
founders shown can be your intro path
Versed AI provides supply chain analytics and visualization software that maps multi-tier supplier networks, enabling companies to gain visibility across their entire supply chain infrastructure and integrate these insights into their existing technology systems.
AI & Machine LearningData & InfrastructureEnterprise SoftwareLogistics & Supply ChainSaaS
Simon Baker(Research Associate)inPascal Wichmann(PhD student)in
Co-investorsFounders FactoryInnovate UKY CombinatorWorking Capital FundCherry VenturesGradient Ventures
52North Health develops NeutroCheck, a diagnostic tool that identifies neutropenia in chemotherapy patients presenting with fever, enabling risk stratification and reducing unnecessary emergency department visits.
BiotechDigital HealthHealthtechMedical DevicesCambridge, GB
Co-investorsMeridian Health VenturesCambridge Angels groupFuture Planet CapitalParkwalk AdvisorsSie VenturesCambridge Innovation Capital+2 more
8power builds 'Fit & Forget' wireless sensors that provide real-time condition monitoring, data and analytics for industrial machinery such as pumps, motors and gearboxes, allowing clients to track remote asset performance and plan maintenance.
Advanced ManufacturingAI & Machine LearningCleantechEnterprise SoftwareHardwareIoTCambridge, GB
Paul Egan(CEO)inGlen Clark(CFO)in
BoardRichard Green(Chairman)
Co-investorsCambridge Angels groupParkwalk Advisors
Abselion develops measurement tools and a platform combining hardware, purpose-built assay formats, and software for biological measurements such as protein quantification.
BiotechDeep TechHardwareMedical DevicesCambridge, GB
Dr Ruizhi Wang(CEO)
Co-investorsCambridge Angels groupM VenturesBusiness Growth FundR42 GroupThe Engine VenturesUntitled Ventures
Allfocal Optics develops nanophotonic display technology based on research from Cambridge University, aimed at improving visual clarity and comfort.
Deep TechHardwareSemiconductorsCambridge, GB
Dr. Pawan Shrestha(Founder)in
Co-investors7percent VenturesEMV CapitalMartlet CapitalCambridge Angels group
Aqdot is a supramolecular chemistry (chem-tech) company that develops proprietary AqFresh air quality and odour/VOC-elimination technology based on encapsulation.
CleantechDeep TechNew Materials
Dr Jing Zhang(Chief Executive Officer & Co-founder)Dr Roger Coulston(Chief Technical Officer & Co-founder)Hugh Rathbone(Chief Commercial Officer)inAlex Anikeeva(Chief Financial Officer)in
BoardTim Wright(Chairman)
Co-investorsProvidence Investment Company LimitedParkwalk AdvisorsBusiness Growth FundIP Group
Axiom Therapeutics runs a drug discovery platform for covalent inhibitors, applying machine learning to speed up physics-based simulations.
BiotechLondon, GB
Ryan Geiser(CEO)inChris Haggard(CTO)inSofia Dahoune(Director)
Co-investorsCreative Destruction Lab (CDL)Entrepreneur FirstLunar VenturesSamos InvestmentsTranspose Platform ManagementVerve Ventures
.jpeg){kind=logo}
Biomodal develops genomic and epigenomic sequencing technologies for life scientists and clinical researchers, enabling simultaneous analysis of genetic data and modified cytosine bases from a single DNA sample.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, GB
BoardShankar BalasubramanianBobby Yerramilli-Rao
Co-investorsGV (Google Ventures)JIMCONew Science VenturesSequoia CapitalAhren Innovation Capital
BIOS develops neural digital therapy technology to deliver treatments for neurological conditions.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB
Oliver Armitage(Founder)inEmil Hewage(Director)in
Co-investorsFifty YearsFOUNDER.orgHeuristic Capital PartnersKern Venture GroupThe Venture CollectiveY Combinator+6 more
bit.bio is a synthetic biology company that engineers human induced pluripotent stem cells into defined cell types for research, drug discovery, and cell therapy applications.
BiotechDeep TechHealthtechMedical Devices
Dr Mark Kotter(Founder)Przemek Obloj(CEO)inEmma PepperellinMark Kotter(Founder)
Co-investorsForesite CapitalBlueYard CapitalARCH Venture PartnersDynamk CapitalGood AI CapitalHarmonix Fund+6 more
BKwai is a software platform that combines InSAR satellite and sensor monitoring data with data science and machine learning to provide structural health insights, movement mapping, and predictive forecasting.
Advanced ManufacturingAI & Machine LearningConstruction TechDeep TechLondon, GB
Sakthy Selvakumaran(CEO)inNiv Magen(Founding CTO)in
Co-investorsEntrepreneur FirstOctopus Ventures
CardiaTec Biosciences is a UK company working on decoding cardiovascular disease biology.
Co-investorsAPEX VenturesCambridge Angels groupMontage Ventures
Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization.
BiotechDigital HealthHealthtechMedical DevicesBoston, US
Timothy Pearson(CEO)Ash Bahl(CSO)inJenny Horsfield(CBO)inStuart McIntosh(CMO)inDavid Sutherland(VP Finance & Controller)
Co-investorsARCH Venture PartnersB Capital GroupB4 CapitalCambridge Innovation CapitalGV (Google Ventures)Lightstone Ventures+2 more
.jpeg){kind=logo}
CellCentric develops inobrodib, a small-molecule oral p300/CBP inhibitor intended to treat multiple myeloma and other cancers.
BiotechHealthtechMedical Devices
Azim Surani(Co-founder)
Co-investorsAvego BioScience CapitalFuture Planet CapitalHBM Healthcare InvestmentsHBM PartnersRA CapitalSofinnova Partners+3 more
Enval develops a microwave-induced pyrolysis technology that recycles low-density and complex plastic packaging waste, converting it into oil feedstock to produce new plastic.
Circular EconomyCleantechNew Materials
Co-investorsAnglia Capital GroupCambridge Angels groupCambridge Capital GroupGEIF Ventures
Kalium Health is developing personalised, at-home health monitoring for chronic kidney disease, aimed at helping healthcare providers and patients track key risks to improve outcomes and reduce costs.
Digital HealthHealthtechMedical DevicesCambridge, GB
Fiona Karet(Chief Medical Officer)in
Co-investorsMartlet CapitalCambridge Angels groupEMV Capital
Nu Quantum develops quantum networking solutions to enable commercial quantum computer scaling.
Deep TechHardwareQuantum ComputingCambridge, GB
Carmen Palacios-Berraquero(Founder)inMatthew Applegate(Founder)
Co-investors7percent VenturesAhren Innovation CapitalAmadeus Capital PartnersEMV CapitalExpeditionsIQ Capital+7 more
.jpeg){kind=logo}
PhoreMost is a biotechnology company developing small molecule drugs and targeted protein degradation therapeutics for cancers with high unmet clinical need, with a lead program (PMC-001) for primary and metastatic brain cancers in Phase 1/2a clinical evaluation.
BiotechMedical DevicesCambridge, GB
Co-investorsAmadeus Capital PartnersAstellas Venture Management LLCCambridge Angels groupAmadeus Capital SAO2h VenturesParkwalk Advisors
Porotech develops MicroLED display technology, supplying components and technology consultancy to help partners manufacture microLED displays.
Deep TechHardwareSemiconductors
Tongtong Zhu(Founder)in
Co-investorsCambridge Angels groupIQ CapitalMartlet CapitalAmeba CapitalSpeedinvest
Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.
BiotechDeep TechHealthtechMedical Devices
Michal Minczuk(Co-Founder)inGabriel Martinez(Chief Scientific Officer & Co-Founder)Claes Gustafsson(Co-Founder)Maria Falkenberg(Co-Founder)Nils-Göran Larsson(Co-Founder)Gabriel Martinez, Ph.D.(Chief Scientific Officer & Co-Founder)
Co-investorsARCH Venture PartnersCambridge Innovation CapitalEIR VenturesAngelini VenturesGV (Google Ventures)HealthCap+2 more
Psyomics builds behavioral health assessment tools, including beseen™, which captures structured data and free text from patients, families, and professionals to support clinical pathways for adults and young people.
Digital HealthHealthtechMental Health
Dr. Melinda Rees(Chief Executive Officer)inRupert Hipwell(Chief Commercial Officer)inAlex Nancekievill(Chief Technology Officer)in
Co-investorsCambridge Angels groupEMV CapitalMartlet Capital
Qkine manufactures and supplies high-purity growth factors and cytokines for research and therapeutic applications, serving life sciences researchers and cell therapy developers.
BiotechDeep TechHealthtechNew MaterialsCambridge, GB
Dr Marko Hyvönen(CSO & Founder)
Co-investorsCambridge Angels groupEMV CapitalMartlet CapitalOxford Investment Opportunity Network (OION)
Riverlane builds quantum error correction hardware and software, including its Deltaflow real-time QEC system, for quantum computer makers.
Cambridge, GB
Steve Brierley(Founder)in
Co-investorsAmadeus Capital PartnersCambridge Innovation CapitalETF PartnersMolten VenturesAltaIR Capital
RoboK offers SiteLens®, an AI computer vision platform that analyzes existing CCTV footage to detect workplace hazards, monitor PPE compliance, identify near misses, and generate safety KPI and compliance reports.
Advanced ManufacturingAI & Machine LearningLogistics & Supply Chain
Co-investorsAI SeedAmadeus Capital PartnersCambridge Angels groupEMV CapitalMartlet Capital
Sorex Sensors develops film bulk acoustic resonator (FBAR) technology for sensor applications in semiconductor markets.
Deep TechHardwareHealthtechIoTSemiconductors
Michael LeGoff(Executive Chairman)
Co-investorsCambridge Angels groupEMV CapitalMartlet Capital
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
Co-investorsCambridge Innovation CapitalFast Track InitiativeM VenturesPfizer Venture InvestmentsSeroba Life SciencesTaiho Ventures, LLC+3 more
T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, GB
Co-investorsCambridge Innovation CapitalF-Prime CapitalSanofi VenturesSofinnova PartnersBusiness Growth FundDigitalis Ventures
Tenyks develops a Visual Intelligence Platform that processes and extracts actionable insights from large collections of visual data and assets.
AI & Machine LearningData & InfrastructureEnterprise SoftwareRetail TechCambridge, GB
Botty Dimanov(CEO)inDmitry KazhdanGeorgia Mason('s Associate)Nathan Da Silva(Hiring)
Co-investorsBlack Mountain VentuesCambridge Angels groupLAUNCHub VenturesRKKVCY CombinatorCSVE Venture Partners+4 more
Wave Photonics develops photonic component libraries and co-packaged optics intellectual property for licensing, including energy-efficient modulator designs and control circuits.
Deep TechHardwareSemiconductorsCambridge, GB
Mateusz Kubica(Founder)inMohsen Kamali(Founder)Rob Thomson(Founder)
Co-investorsBerliner Volksbank VenturesQAI VenturesRedstoneTane FundUK Innovation & Science Seed Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Cambridge Touch TechnologiesCarrickFocalPointImmaterialMattaNeoPhoreParagrafPervasIDPolyProXSanoSignaloidSqwishSTORMZ Factor
Portfolio news
latest coverage across their companiesCellCentric · finsmes.com · May 6, 2026
Pretzel Therapeutics · finsmes.com · Jul 14, 2025
Frequently asked questions
- How many investments has University of Cambridge Enterprise made?
- University of Cambridge Enterprise has 43 tracked investments, including 1 dated in the last 24 months.
- What stage does University of Cambridge Enterprise invest at?
- University of Cambridge Enterprise invests at the Pre-Seed, Seed stages.
- What sectors does University of Cambridge Enterprise focus on?
- University of Cambridge Enterprise focuses on AgTech, Biotech, Cleantech, Data & Infrastructure, Deep Tech, Energy, Medical Devices, New Materials, SaaS, Sector Agnostic, Semiconductors.
- Where is University of Cambridge Enterprise located?
- University of Cambridge Enterprise is headquartered in Cambridge, GB.
- Who does University of Cambridge Enterprise co-invest with?
- University of Cambridge Enterprise most often shares deals with Cambridge Angels group, Amadeus Capital Partners, Cambridge Innovation Capital, among 7 tracked co-investors.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Oxford Technology is a UK investment manager running tax-efficient SEIS and EIS funds that back startup and early-stage technology companies in and around Oxford. It has invested in Oxford-area science and technology startups since 1983.
GVFL Limited is a venture capital firm based in Ahmedabad, India, investing in early- to growth-stage startups across multiple sectors, with a focus on the India market and startups from Gujarat.